LENZ Therapeutics Stock Performance
as on November 4, 2026 at 4:57 am IST
Day's Low
Day's High
$3.08$3.73
14.21%
Downside
3.90%
Upside

52 Week's Low
52 Week's High
$2.80$32.13
22.01%
Downside
794.99%
Upside

LENZ Therapeutics share price movements today
- Previous Close
- $3.05
- Open
- $3.16
- Volume
- 1.2M
- Market Cap
- $95.8M
- Day's Low - High
- $3.08 - $3.73
- 52 Week Low - High
- $2.80 - $32.13
LENZ Therapeutics Historical Returns
- 1 Month Return
- -14.8 %
- 3 Month Return
- -38.94 %
- 1 Year Return
- -89.08 %
- 3 Year Return
- 0 %
- 5 Year Return
- 0 %
LENZ Therapeutics Stock Fundamentals & Key Indicators
Check LENZ Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$95.8M
EPS (TTM)
-4.09
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-0.68
Industry PE ratio
-3.13
PEG Ratio
0.01
EBITDA
-125.5M
Revenue (TTM)
21.5M
Profit Margin
80.21%
Return On Equity TTM
-59.44%
LENZ Therapeutics vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of LENZ Therapeutics with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | Dividend Yield % |
|---|---|---|---|---|---|---|
| Buy | $95.8M | NA | -0.68 | 80.21% | 0.00% | |
| Neutral | $88.5B | -36.16% | -27.78 | -12.57% | 0.00% | |
| StrongBuy | $141.7B | 192.56% | 32.27 | 86.04% | 0.00% | |
| Buy | $95.5B | 47.41% | 19.76 | 85.77% | 0.40% |
Stock Returns calculator for LENZ Therapeutics Stock including INR - Dollar returns
The LENZ Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Investment Value
₹1,00,000
LENZ Therapeutics investment value today
Current value as on today
₹13,725
Returns
Returns from LENZ Therapeutics Stock
Dollar Impact
₹872 (+0.87%)
Analyst Recommendation on LENZ Therapeutics Stock
Based on 3 analysts
66.67%
Buy
33.33%
Hold
0.00%
Sell
Based on 3 analysts, 66.66666666666666% of analysts recommend a 'BUY' rating for LENZ Therapeutics. Average target price of $18.67
LENZ Therapeutics Share Price Target
Get share price movements and forecasts by analysts on LENZ Therapeutics.
What analysts predicted
80.77%UPSIDE
Target Price
$18.67
Current Price
$3.59
Analyzed by
3 Analysts
High
$16
Target
$18.67
Low
$4
LENZ Therapeutics target price $18.67, a slight upside of 80.77% compared to current price of $3.59. According to 3 analysts rating.
Indian Investors' Interest in LENZ Therapeutics Stock
Search interest for LENZ Therapeutics Stock has decreased by -67% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
LENZ Therapeutics Quarterly Profit & Loss
All numbers in Millions USD
LENZ Therapeutics Annual Profit & Loss
All numbers in Millions USD
LENZ Therapeutics Quarterly Cash Flow
All numbers in Millions USD
LENZ Therapeutics Annual Cash Flow
All numbers in Millions USD
LENZ Therapeutics News & Key Events

Today's Timeline - 28 October
Thu, 02:16 AM
-LENZ reports Q3 EPS of 99c, exceeding consensus, with product sales growth of 50% for VIZZ.
Thu, 02:51 AM
-LENZ Therapeutics announces major restructuring, including a 75% workforce reduction and CEO transition to Dan Chevallard.
Insights on LENZ Therapeutics
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
NO EFFECTAgainst Peers

In the last 1 year, Moderna, Inc. Common Stock has given 786.5% return, outperforming this stock by 875.6%
NEGATIVE IMPACTPrice Dip

In the last 6 months, LENZ stock has moved down by -65.7%
About LENZ Therapeutics
| Organisation | LENZ Therapeutics |
| Headquarters | 201 Lomas Santa Fe Drive, Solana Beach, CA, 92075, US |
| Industry | Biotechnology |
| CEO | Evert Schimmelpennink |
Key Management of LENZ Therapeutics
Name | Title |
|---|---|
Mr. Shawn Olsson | Chief Commercial Officer |
Mr. Marc G. Odrich M.D. | Chief Medical Officer |
Mr. Domenick Porfidia | Vice President of Sales |
Mr. David Choromanski | Vice President of Marketing |
Ms. Melissa Rosness | Senior Vice President of Manufacturing Operations |
Kris Gambelin | Senior Vice President of Regulatory & Clincal Operations |
Mr. Evert B. Schimmelpennink | President, CEO, Secretary & Director |
Mr. James W. McCollum | Co-Founder & Director |
FAQs
What is LENZ Therapeutics share price today?
LENZ Therapeutics share price today is $3.59 as on . LENZ Therapeutics share today touched a day high of $3.73 and a low of $3.08.
What is the 52 week high and 52 week low for LENZ Therapeutics share?
LENZ Therapeutics share touched a 52 week high of $32.13 on and a 52 week low of $2.80 on . LENZ Therapeutics stock price today i.e. is trending at $3.59,which is 88.83% down from its 52 week high and 28.21% up from its 52 week low.
What is LENZ Therapeutics's market capitalisation today?
LENZ Therapeutics market capitalisation is $0.00T as on .
How to invest in LENZ Therapeutics Stock (LENZ) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for LENZ Therapeutics on INDmoney app. Click on Buy button.
What is the minimum amount required to buy LENZ Therapeutics Stock (LENZ) from India?
Indian investors can start investing in LENZ Therapeutics (LENZ) shares with as little as ₹94.73999786376953 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹947.40 in LENZ Therapeutics stock (as per the Rupee-Dollar exchange rate as on ).
Based on LENZ Therapeutics share’s latest price of $3.59 as on November 3, 2026 at 11:27 pm IST, you will get 2.7855 shares of LENZ Therapeutics. Learn more about
fractional shares .